253 related articles for article (PubMed ID: 3024950)
1. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
Greene DA
Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
[TBL] [Abstract][Full Text] [Related]
2. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
Greene DA
Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
4. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
Greene DA; Lattimer SA
Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
Greene DA; Lattimer-Greene S; Sima AA
Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
[TBL] [Abstract][Full Text] [Related]
7. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
Greene DA; Chakrabarti S; Lattimer SA; Sima AA
J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
[TBL] [Abstract][Full Text] [Related]
8. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Greene DA; Lattimer SA; Sima AA
Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
[TBL] [Abstract][Full Text] [Related]
9. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
10. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
Greene DA; Mackway AM
Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
[TBL] [Abstract][Full Text] [Related]
11. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
Lu KM; Zhong XL; Zhu XX; Zhu QY
Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
[TBL] [Abstract][Full Text] [Related]
12. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
Greene DA; Lattimer SA
J Clin Invest; 1983 Sep; 72(3):1058-63. PubMed ID: 6309904
[TBL] [Abstract][Full Text] [Related]
13. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy.
Greene DA; Lattimer SA
Ann N Y Acad Sci; 1986; 488():334-40. PubMed ID: 3034118
[No Abstract] [Full Text] [Related]
14. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
Greene DA; Lattimer SA; Sima AA
N Engl J Med; 1987 Mar; 316(10):599-606. PubMed ID: 3027558
[TBL] [Abstract][Full Text] [Related]
15. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
[TBL] [Abstract][Full Text] [Related]
16. A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve. Correction by an aldose reductase inhibitor or myo-inositol administration.
Greene DA; Lattimer SA; Carroll PB; Fernstrom JD; Finegold DN
J Clin Invest; 1990 May; 85(5):1657-65. PubMed ID: 2185278
[TBL] [Abstract][Full Text] [Related]
17. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
18. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
19. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
[TBL] [Abstract][Full Text] [Related]
20. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
Sima AA; Dunlap JA; Davidson EP; Wiese TJ; Lightle RL; Greene DA; Yorek MA
Diabetes; 1997 Feb; 46(2):301-6. PubMed ID: 9000708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
